H. Chen

机构：Ipsen (United States)

发表论文 3 篇 · 总被引 2 次 · h-index 1

代表论文

• O-1 Liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: Sensitivity analysis of survival from the NAPOLI 3 trial (2023 · Annals of Oncology · 被引 1)
• 161O RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC) (2023 · Journal of Thoracic Oncology · 被引 1)
• P3.03-007 LCMC2: Expanded Profiling of Lung Adenocarcinomas Identifies ROS1 and RET Rearrangements and TP53 Mutations as a Negative Prognostic Factor (2017 · Journal of Thoracic Oncology)